<DOC>
	<DOCNO>NCT00135512</DOCNO>
	<brief_summary>This study design evaluate efficacy safety major depressive disorder patient .</brief_summary>
	<brief_title>Study Of 323U66 SR In Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Inclusion criterion : Met DSMIVTR criterion major depressive disorder current episode least 8 week prior screen visit . Must give write informed consent . But patient 20 , patient himself/herself his/her proxy consenter must give write informed consent . Must rating score outline . Exclusion criterion : Current past history seizure disorder brain injury . Current past history anorexia bulimia nervosa . History manic episode . Past current DSM IVTR diagnosis schizophrenia psychotic disorder . Diagnosis substance abuse ( alcohol drug ) DSMIVTR criterion . Pregnant , possibly pregnant lactating . Must suicidal . Blood pressure SBP &gt; 160mmHg , DBP &gt; 100mmHg . History complication cancer malignant tumour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>MDD</keyword>
</DOC>